Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase I Trial of Bortezomib and Sunitinib
This study is currently recruiting participants.
Study NCT00720148   Information provided by Emory University
First Received: July 18, 2008   Last Updated: July 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Refractory Solid Tumors
Interventions listed in this trial
Sunitinib and Bortezomib
Additional drug interventions recognized in this trial
Bortezomib
Sunitinib
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Emory University
Millennium Pharmaceuticals, Inc.
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services